D. Western Therapeutics Institute, Inc. (4576.T)
JPY 102.0
(-1.92%)
JPY 102.0
(-1.92%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 875.59 Million JPY | 3.29% |
| 2022 | 847.69 Million JPY | 302.75% |
| 2021 | 210.47 Million JPY | -38.1% |
| 2020 | 340 Million JPY | -5.56% |
| 2019 | 360 Million JPY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 1.08 Billion JPY | 11.24% |
| 2024 Q1 | 979.83 Million JPY | 11.9% |
| 2023 Q4 | 875.59 Million JPY | 10.64% |
| 2023 FY | 875.59 Million JPY | 3.29% |
| 2023 Q3 | 791.36 Million JPY | 2.98% |
| 2023 Q2 | 768.48 Million JPY | -0.31% |
| 2023 Q1 | 770.85 Million JPY | -8.99% |
| 2022 Q4 | 847 Million JPY | -14.73% |
| 2022 Q3 | 993.26 Million JPY | 0.0% |
| 2022 FY | 847.69 Million JPY | 302.75% |
| 2021 FY | 210.47 Million JPY | -38.1% |
| 2020 FY | 340 Million JPY | -5.56% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 767.03 Million JPY | -14.154% |
| PRISM BioLab Co.,LTD | - JPY | -Infinity% |
| GNI Group Ltd. | 2 Billion JPY | 56.22% |
| Linical Co., Ltd. | 1.49 Billion JPY | 41.625% |
| Trans Genic Inc. | 1.32 Billion JPY | 34.021% |
| MEDINET Co., Ltd. | 781 Thousand JPY | -112012.42% |
| Soiken Holdings Inc. | - JPY | -Infinity% |
| Cytori Cell Research Institute, Inc. | 2.34 Billion JPY | 62.694% |
| AnGes, Inc. | 214.94 Million JPY | -307.352% |
| OncoTherapy Science, Inc. | 106.84 Million JPY | -719.472% |
| Nxera Pharma Co., Ltd. | 63.21 Billion JPY | 98.615% |
| Immuno-Biological Laboratories Co., Ltd. | 84.56 Million JPY | -935.463% |
| NanoCarrier Co., Ltd. | 1.1 Billion JPY | 21.04% |
| Carna Biosciences, Inc. | 28.4 Million JPY | -2982.874% |
| CanBas Co., Ltd. | - JPY | -Infinity% |
| RaQualia Pharma Inc. | 39.05 Million JPY | -2142.248% |
| Chiome Bioscience Inc. | - JPY | -Infinity% |
| Kidswell Bio Corporation | 1.83 Billion JPY | 52.36% |
| PeptiDream Inc. | 19.63 Billion JPY | 95.541% |
| Oncolys BioPharma Inc. | 161.1 Million JPY | -443.512% |
| Ribomic Inc. | - JPY | -Infinity% |
| SanBio Company Limited | 397 Million JPY | -120.554% |
| Healios K.K. | 450 Million JPY | -94.577% |
| BrightPath Biotherapeutics Co., Ltd. | - JPY | -Infinity% |
| Kubota Pharmaceutical Holdings Co., Ltd. | - JPY | -Infinity% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | - JPY | -Infinity% |
| CellSource Co., Ltd. | 77.29 Million JPY | -1032.859% |
| FunPep Company Limited | - JPY | -Infinity% |
| Kringle Pharma, Inc. | - JPY | -Infinity% |
| Stella Pharma Corporation | 773.29 Million JPY | -13.23% |
| TMS Co., Ltd. | - JPY | -Infinity% |
| Noile-Immune Biotech Inc. | - JPY | -Infinity% |
| Cuorips Inc. | - JPY | -Infinity% |
| K Pharma,Inc. | - JPY | -Infinity% |
| Takara Bio Inc. | 788 Million JPY | -11.116% |
| ReproCELL Incorporated | - JPY | -Infinity% |
| PhoenixBio Co., Ltd. | 491.35 Million JPY | -78.202% |
| StemCell Institute Inc. | 6.67 Million JPY | -13015.608% |
| Japan Tissue Engineering Co., Ltd. | - JPY | -Infinity% |
| CellSeed Inc. | 143.75 Million JPY | -509.112% |